Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
Key Insights Roper Technologies' estimated fair value is US$719 based on 2 Stage Free Cash Flow to Equity Current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback